About us

  • Since its inception, OBD has focused on:-
  • »developing and standardising its technology for a set of unique diagnostic applications
    »establishing collaborations and feasibility studies with leading academic research groups
    »filing of patents, and securing newly generated intellectual property and technical know-how

  • OBD is setting up regional diagnostic health-care service providers in South-East Asia, Australia, Europe and the Middle East, to commercialize its technology in different diagnostic and therapeutic areas.
  • In the short term OBD is looking at specific diseases and drug targets where the technology would have the greatest effect including breast cancer, heart disease, liver cancer and melanoma.
  • OBD holding company is registered in England and Wales and has a subsidiary in Singapore.